Access for Dual Eligibles

Mitchell, Laurl
April 2006
Pharmaceutical Executive;Apr2006, Vol. 26 Issue 4, p154
Trade Publication
The article reports on the impact of the new Medicare prescription drug benefit or Part D plan on top pharmaceutical brands in the U.S. The dual eligible population or those Medicaid beneficiaries who also qualify for Part D have less access to the leading brands prescribed for seniors due to the restrictive Preferred Drug Lists in various state's Medicaid initiatives.


Related Articles

  • Medicare news keeps getting worse. Gratty, Bob // Dermatology Times;Jun2006, Vol. 27 Issue 6, p5 

    The article presents the 2006 Medicare Trustees Report which admonishes that Medicare will run out of money by 2018 in the U.S. The study impacted the practice of physicians who have been attempting to eradicate the Sustainable Growth Rate component of Medicare payment formula. The trustees...

  • Medicare enrollment period opens today. Cassell, Heather // Bay Area Reporter;11/15/2007, Vol. 37 Issue 46, p13 

    The article reports on the opening of the 2008 Medicare beneficiaries enrollment in San Francisco, California. It is stated that November 15, 2007 will be the opening of the enrollment period for 2008. Health care advocates suggests that beneficiaries review and switch plans, if necessary, by...

  • Medicare CCI Edits Extended to All Providers. Kander, Mark // ASHA Leader;12/27/2005, Vol. 10 Issue 17, p3 

    The article presents questions and answers advisory on topics related to Correct Coding Initiatives (CCI) in the U.S. One questions the new features of the CCI edits in 2006. Another questions whether speech language pathology services related to an Speech Generating Device. Furthermore, one...

  • How Medicare Reimburses For Some In-Office Drugs. McCune, Donna // Review of Ophthalmology;Jun2005, Vol. 12 Issue 6, p30 

    Presents a question and answer advisory on how Medicare reimburses for some drugs utilized in the office in the U.S. Coverage of the Medicare program on outpatient drugs; Condition to the reimbursement of drugs; Basis for the amount of reimbursement.

  • Changes In Medicaid Prescription Volume And Use In The Wake Of Medicare Part D Implementation. Bruen, Brian K.; Miller, Laura M. // Health Affairs;Jan/Feb2008, Vol. 27 Issue 1, p196 

    Implementation of the Medicare drug benefit resulted in a major shift of prescription drug spending from Medicaid to Medicare. Data indicate that Medicaid programs experienced substantial changes in the volume and types of prescriptions used by enrollees. Medicaid prescription volume and total...

  • Pharmacy: No longer out in the cold. Anderson, Steven C. // Drug Topics;Jun2010, Vol. 154 Issue 6, p7 

    The author reflects on the concern of the National Association of Chain Drug Stores (NACDS) regarding the importance of taking the right medications in the right ways. He argues on the growing realization that the costs of poor medication adherence cannot be rejected. An overview of NACDS reform...

  • Isn't a 'Benefit' Meant To Be Something Good? Dolliver, Mark // Adweek;3/6/2006, Vol. 47 Issue 10, p24 

    The article reports that a new poll of senior citizens by the Kaiser Family Foundation finds 45 percent people saying they have enrolled or intend to enroll in one of the Medicare prescription-drug benefit program's drug plans. Among seniors who have decided not to sign up, two-thirds said a...

  • CMS piecing together Medicare Part D and Part B. Gebhart, Fred // Drug Topics;3/21/2005, Vol. 149 Issue 6, p12 

    The U.S. Centers for Medicare & Medicaid Services (CMS) is proposing additional changes to Medicare out-patient programs in March 2005. The government office requested proposals for a system to calculate the true out-of-pocket cost for patients buying drugs under the Part D benefit that begins...

  • Drug Prices and Value for Money: The Australian Pharmaceutical Benefits Scheme. Henry, David A.; Hill, Suzanne R.; Harris, Anthony // JAMA: Journal of the American Medical Association;11/23/2005, Vol. 294 Issue 20, p2630 

    The article offers an analysis of the Australian Pharmaceutical Benefits Scheme (PBS). PBS guarantees Australians access to subsidized medicines. It is a central feature of Medicare, the universal health care program in Australia. The Pharmaceutical Benefits Advisory Committee decides which...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics